Cargando…

Medicinal Immunoglobulin G Products (2020) Show High Infectivity Neutralizing Activity Against Seasonal Influenza Virus Strains Selected for Future Vaccines (2020–2022)

Immunoglobulin (Ig)G medicinal products manufactured in 2020 were tested for infectivity neutralization and hemagglutination inhibition against World Health Organization-selected influenza strains included in worldwide vaccines 2020–2022. The IgG batches (from US plasma) showed potent activity. Intr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Díez, José María, Casals, Daniel, Romero, Carolina, Gajardo, Rodrigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253882/ https://www.ncbi.nlm.nih.gov/pubmed/35794931 http://dx.doi.org/10.1093/ofid/ofac216

Ejemplares similares

Surveillance of anti-SARS-CoV-2 antibodies in plasma pools and in immunoglobulin medicinal products manufactured since 2020 has shown high neutralizing activity against SARS-CoV-2 and current variants
por: Romero, Carolina, et al.
Publicado: (2023)

Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins
por: Díez, José María, et al.
Publicado: (2021)

No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic
por: Schwaiger, Julia, et al.
Publicado: (2020)

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic( )
por: Farcet, Maria R, et al.
Publicado: (2021)

Effective presence of antibodies against common human coronaviruses in immunoglobulin medicinal products
por: Díez, José María, et al.
Publicado: (2022)

Estimating the Impact of Low Influenza Activity in 2020 on Population Immunity and Future Influenza Seasons in the United States
por: Lee, Kyueun, et al.
Publicado: (2021)

Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
por: Onodera, Hiroyuki, et al.
Publicado: (2017)

Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens
por: Díez, José-María, et al.
Publicado: (2020)

End of season 2022/2023 quadrivalent influenza vaccine effectiveness in preventing influenza in primary care in Portugal
por: Kislaya, Irina, et al.
Publicado: (2023)

Different Starting Dominant Strain of Seasonal Influenza in China and Other Neighboring Asian Countries in 2019−2020 Winter Season
por: Yang, Jing, et al.
Publicado: (2020)

Influenza vaccine effectiveness in patients hospitalized with severe acute respiratory infection in Lithuania during the 2019–2020 influenza season: a test negative case – control study
por: Vaikutyte, Roberta, et al.
Publicado: (2023)

Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
por: Díez, José María, et al.
Publicado: (2020)

COVID-19 versus seasonal influenza 2019–2020: USA
por: Wormser, Gary P.
Publicado: (2020)

SARS‐CoV‐2 in asymptomatic Danish infants and their mothers from April 2020 to January 2022
por: Malon, Michelle, et al.
Publicado: (2022)

Epidemiological and Virological Surveillance of Seasonal Influenza Viruses — China, 2020–2021
por: Huang, Weijuan, et al.
Publicado: (2021)

Projecting the Combined Health Care Burden of Seasonal Influenza and COVID-19 in the 2020–2021 Season
por: Du, Zhanwei, et al.
Publicado: (2022)

Assessment of Equine Influenza Virus Status in the Republic of Korea from 2020 to 2022
por: Lim, Seong-In, et al.
Publicado: (2023)

Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany)
por: Heinzinger, Susanne, et al.
Publicado: (2021)

Very little influenza in the WHO European Region during the 2020/21 season, weeks 40 2020 to 8 2021
por: Adlhoch, Cornelia, et al.
Publicado: (2021)

Reciprocal circulation pattern of SARS-CoV-2 and influenza viruses during the influenza seasons 2019/2020 and 2020/2021 in the Bavarian Influenza Sentinel (Germany) – CORRIGENDUM
por: Heinzinger, Susanne, et al.
Publicado: (2022)

SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021–2022 influenza season
por: Tang, Cynthia Y., et al.
Publicado: (2022)

Hospital Strain and COVID-19 Fatality — England, April 2020–March 2022
por: Lin, Tengfei, et al.
Publicado: (2022)

1444. Influenza Surveillance in the Veterans Health Administration (VHA): 2020-2021 Season
por: Lucero-Obusan, Cynthia A, et al.
Publicado: (2021)

What Affected Primary Care Patients’ Decisions to Receive the Seasonal Influenza Vaccine in the 2020 to 2021 Season?
por: Kajikawa, Natsuki, et al.
Publicado: (2022)

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2020–21 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2020)

COVID‐19 restrictions probably brought the 2019–2020 Finnish influenza season to an early end and led to fewer respiratory viruses among infants
por: Kelloniemi, Sallamaria, et al.
Publicado: (2021)

Serological Surveillance of Influenza D Virus in Ruminants and Swine in West and East Africa, 2017–2020
por: Sanogo, Idrissa Nonmon, et al.
Publicado: (2021)

Seasonal and inter‐seasonal RSV activity in the European Region during the COVID‐19 pandemic from autumn 2020 to summer 2022
por: Meslé, Margaux M. I., et al.
Publicado: (2023)

Evaluation of influenza vaccination coverage in Shanghai city during the 2016/17 to 2020/21 influenza seasons
por: Wu, Linlin, et al.
Publicado: (2022)

Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022–2023 Winter Season
por: Moss, Stephen, et al.
Publicado: (2023)

1709. Influenza Surveillance in the U.S. Department of Veterans Affairs (VA): 2019-2020 Season
por: Lucero-Obusan, Cynthia, et al.
Publicado: (2020)

Genetic characterisation of the influenza viruses circulating in Bulgaria during the 2019–2020 winter season
por: Korsun, Neli, et al.
Publicado: (2021)

Structuring the Future Residency Recruitment Seasons: Applicants’ Perspective on the Virtual Experience during the 2020–2021 Interview Season
por: Estevez, Tanya Peguero, et al.
Publicado: (2022)

Bronchiolitis epidemics in France during the SARS-CoV-2 pandemic: The 2020–2021 and 2021–2022 seasons
por: Vaux, Sophie, et al.
Publicado: (2022)

Epidemiological Patterns of Seasonal Respiratory Viruses during the COVID-19 Pandemic in Madagascar, March 2020–May 2022
por: Razanajatovo, Norosoa Harline, et al.
Publicado: (2022)

Developing forecasting model for future pandemic applications based on COVID-19 data 2020–2022
por: Wan Mohamad Nawi, Wan Imanul Aisyah, et al.
Publicado: (2023)

Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
por: Dawood, Fatimah S., et al.
Publicado: (2020)

Cell-Adapted Mutations and Antigenic Diversity of Influenza B Viruses in Missouri, 2019–2020 Season
por: Tang, Cynthia Y., et al.
Publicado: (2021)

Estimated Incidence of Seasonal Influenza in China From 2010 to 2020 Using a Multiplier Model
por: Wang, Qiang, et al.
Publicado: (2022)

Investigating the Genetic Diversity of H5 Avian Influenza Viruses in the United Kingdom from 2020–2022
por: Byrne, Alexander M. P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2gbkh1lprmnk8vv542gcduias9